medigraphic.com
ISSN 2078-7170 (Electronic)

2019, Number 3

<< Back Next >>

CorSalud 2019; 11 (3)

Advances in the knowledge of the molecular and cellular bases of congenital heart diseases. Part 1 of 2: Cardiac morphogenesis

Taboada LN

Language: Portugués
References: 28
Page: 233-240
PDF size: 380.35 Kb.


ABSTRACT

Congenital heart diseases are the most common congenital defect in humans. Many studies indicate that the cardiac development is tightly regulated by different cell signaling pathways and genetically controlled morphological events. The identification of new genes involved in the cardiogenesis process is very useful in order to know the molecular and cellular mechanisms by which the broad phenotypic spectrum of congenital heart disease is generated. An updated bibliographic review was carried out, with the aim of identifying the most recent advances in the knowledge of the molecular and cellular bases of congenital heart disease. This knowledge allows a more effective classification of these congenital defects and a future optimization of the individualized treatment for each patient, in addition to offering possible specific and susceptible points of intervention that would allow the prevention of some of these more frequent congenital defects in humans.


REFERENCES

  1. Taboada Lugo N. Papel del ácido fólico, zinc y cobre en la prevención primaria de los defectos congénitos. Rev Cuban Med Gen Integr [Internet]. 2016 [citado 6 Oct 2018];32(4). Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/167/110

  2. Andersen TA, Troelsen KL, Larsen LA. Of mice and men: Molecular genetics of congenital heart disease. Cell Mol Life Sci. 2014;71(8):1327‑52.

  3. Bouma BJ, Mulder BJ. Changing landscape of congenital heart disease. Circ Res. 2017;120(6): 908-22.

  4. Cao Y, Wang J, Wei C, Hou Z, Li Y, Zou H, et al. Genetic variations of NKX2-5 in sporadic atrial septal defect and ventricular septal defect in Chi-nese Yunnan population. Gene. 2016;575(1):29‑33.

  5. Postma AV, Bezzina CR, Christoffels VM. Genetics of congenital heart disease: The contribution of the noncoding regulatory genome. J Hum Genet. 2016;61(1):13-9.

  6. Lalani SR, Belmont JW. Genetic basis of congeni-tal cardiovascular malformations. Eur J Med Ge-net. 2014;57(8):402‑13.

  7. Edwards JJ, Gelb BD. Genetics of congenital heart disease. Curr Opin Cardiol. 2016;31(3):235-41.

  8. Sifrim A, Hitz MP, Wilsdon A, Breckpot J, Turki SH, Thienpont B, et al. Distinct genetic architec-tures for syndromic and nonsyndromic congeni-tal heart defects identified by exome sequencing. Nat Genet. 2016;48(9):1060-5.

  9. Pawlak M, Niescierowicz K, Winata CL. Decoding the heart through next generation sequencing ap-proaches. Genes (Basel) [Internet]. 2018 [citado 6 Oct 2018];9(6):289. Disponible en: https://www.mdpi.com/2073-4425/9/6/289/htm

  10. LaHaye S, Corsmeier D, Basu M, Bowman JL, Fitzgerald-Butt S, Zender G, et al. Utilization of whole exome sequencing to identify causative mutations in familial congenital heart disease. Circ Cardiovasc Genet. 2016;9(4):320-9.

  11. Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2014;59(1):5-15.

  12. Agopian AJ, Mitchell LE, Glessner J, Bhalla AD, Sewda A, Hakonarson H, et al. Genome-wide as-sociation study of maternal and inherited loci for conotruncal heart defects. PLoS One. [Internet]. 2014 [citado 9 Oct 2018];9(5):e96057. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011736/pdf/pone.0096057.pdf

  13. Taboada Lugo N, Herrera Martínez M. Mecanis-mos epigéneticos y vía de señalización Notch en el origen de diferentes defectos congénitos. Me-dicentro [Internet]. 2018 [citado 9 Oct 2018];22(3): 197-207. Disponible en: http://medicentro.sld.cu/index.php/medicentro/article/view/2645/2213

  14. Chen H, VanBuren V. A provisional gene regula-tory atlas for mouse heart development. PLoS ONE [Internet]. 2014 [citado 9 Oct 2018];9(1): e83364. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083364

  15. Deng X, Zhou J, Li FF, Yan P, Zhao EY, Hao L, et al. Characterization of nodal/TGF-lefty signaling pathway gene variants for possible roles in con-genital heart diseases. PLoS One [Internet]. 2014 [citado 9 Oct 2018];9(8):e104535. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128709/pdf/pone.0104535.pdf

  16. Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ, Lemke K, et al. Global genetic analysis in mice unveils central role for cilia in congenital heart disease. Nature. 2015;521(7553):520-4.

  17. Kerstjens-Frederikse WS, van de Laar IM, Vos YJ, Verhagen JM, Berger RM, Lichtenbelt KD, et al. Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their families. Genet Med. 2016;18(9):914-23.

  18. Moore KL, Persaud TVN. Aparato Cardiovascular. En: Embriología Clínica. 8ª ed. Barcelona: Else-vier; 2011. p. 286-336.

  19. Ugur B, Chen K, Bellen HJ. Drosophila tools and assays for the study of human diseases. Dis Mod-el Mech. 2016;9(3):235-44.

  20. Giraldo M, Parra S, Rojas M. Señalización Celular. En: Patiño PJ, editor. Biología de la célula. Antio-quia: Fondo Editorial Biogénesis; 2014. p.219-31.

  21. Sánchez Hernández D, Guerrero Vega I. Función de ihog, boi, dally y dmwif en la formación del gradiente morfogenético de hedgehog en el disco imaginal de ala de drosophila. Análisis de la di-vergencia funcional de los factores wif-1 humano y de Drosophila [Tesis Doctoral en Internet]. Ma-drid: Universidad Autónoma de Madrid; 2013 [ci-tado 10 Oct 2018]. Disponible en: https://repositorio.uam.es/xmlui/handle/10486/662022

  22. Calcagni G, Unolt M, Digilio MC, Baban A, Versac-ci P, Tartaglia M, et al. Congenital heart disease and genetic syndromes: New insights into molec-ular mechanisms. Expert Rev Mol Diagn. 2017; 17(9):861-70.

  23. An Y, Duan W, Huang G, Chen X, Li L, Nie C, et al. Genome-wide copy number variant analysis for congenital ventricular septal defects in Chinese Han population. BMC Med Genomics [Internet]. 2016[citado 6 Oct 2018];9:2. Disponible en: https://bmcmedgenomics.biomedcentral.com/track/pdf/10.1186/s12920-015-0163-4

  24. Han H, Chen Y, Liu G, Han Z, Zhao Z, Tang Y. GATA4 transgenic mice as an in vivo model of congenital heart disease. Int J Mol Med. 2015; 35(6):1545-53.

  25. Lantigua Cruz A. Defectos congénitos de origen genético y ambiental. En: Lantigua Cruz A. Intro-ducción a la Genética Médica. 2ª Ed. La Habana: Editorial Ciencias Médicas; 2011. p. 306-41.

  26. Sanchez-Castro M, Pichon O, Briand A, Poulain D, Gournay V, David A, et al. Disruption of the SE-MA3D gene in a patient with congenital heart de-fects. Hum Mutat. 2015;36(1):30-3.

  27. Li F, Zhou J, Zhao DD, Yan P, Li X, Han Y, et al. Characterization of SMAD3 gene variants for pos-sible roles in ventricular septal defects and other congenital heart diseases. PLoS ONE [Internet]. 2015 [citado 10 Oct 2018];10(6):e0131542. Dispo-nible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131542

  28. Theis JL, Hrstka SC, Evans JM, O'Byrne MM, de Andrade M, O'Leary PW, et al. Compound heter-ozygous NOTCH1 mutations underlie impaired cardiogenesis in a patient with hypoplastic left heart syndrome. Hum Genet. 2015;134(9):1003-11.




2020     |     www.medigraphic.com